Certainly it was good news when Rubius Therapeutics Inc. announced its intention to open a pharmaceutical manufacturing facility in Rhode Island. It didn’t have to work out this way. But when it became known that Rubius was looking for a place to create a new class of medicine, the Raimondo administration jumped in, armed with…
This article is available only to PBN Subscribers. To get unlimited access, please subscribe by following the link below.
Already a subscriber? Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.